Literature DB >> 3236561

Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema.

T Jennings1, M M Rusin, H H Tessler, J G Cunha-Vaz.   

Abstract

Cystoid macular edema (CME) is a major cause of visual impairment and is thought to be due to abnormal perifoveal capillary permeability. Posterior sub-Tenon's corticosteroid injections are used to improve the visual acuity in CME, although their mechanism of action is uncertain. In this study, visual acuity, blood retinal barrier (BRB) permeability, and fluorescein angiograms were recorded immediately before and one and four weeks after the administration of steroid injections. Ten patients (12 treated eyes) with CME secondary to uveitis were studied. Visual improvement, defined as an increase in at least two lines of Snellen visual acuity, was seen in half of the treated eyes. In some patients, these improvements were not directly related to changes in the BRB permeability or the amount of macular fluid. Posterior sub-Tenon's corticosteroid injections do not consistently affect blood retinal barrier permeability.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3236561

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  17 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Accurate placement of corticosteroids into the sub-Tenon's space provides good drug penetration into the eye.

Authors:  A A Okada; T Wakabayashi
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

3.  Periocular corticosteroid therapy: comments.

Authors:  V Vedantham
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 4.  Pharmacokinetics of ophthalmic corticosteroids.

Authors:  C N McGhee
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

5.  The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.

Authors:  P Tranos; R Scott; H Zambarakji; H Zambarajki; W Ayliffe; C Pavesio; D G Charteris
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

Review 6.  Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.

Authors:  A D Dick; M Azim; J V Forrester
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

7.  Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration.

Authors:  P L Penfold; L Wen; M C Madigan; M C Gillies; N J King; J M Provis
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

8.  Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.

Authors:  Zhenyu Dong; Kenichi Namba; Nobuyoshi Kitaichi; Chiho Goda; Mizuki Kitamura; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

9.  Effects of a new dexamethasone-delivery system (Surodex) on experimental intraocular inflammation models.

Authors:  Masuhiro Kodama; Jiro Numaga; Atsushi Yoshida; Toshikatsu Kaburaki; Tetsuro Oshika; Yujiro Fujino; Guey-Shuang Wu; Narsing A Rao; Hidetoshi Kawashima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-04       Impact factor: 3.117

10.  Periocular corticosteroid injections in uveitis: effects and complications.

Authors:  H Nida Sen; Susan Vitale; Sapna S Gangaputra; Robert B Nussenblatt; Teresa L Liesegang; Grace A Levy-Clarke; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; John H Kempen
Journal:  Ophthalmology       Date:  2014-07-11       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.